Recently, we discovered that insulin‐like growth factor‐binding protein‐4 (IGFBP‐4) can robustly protect against MI via limiting early‐stage DNA damage occurrence and ischaemic injury.4 Here, IGFBP4 is linked to myocardial infarction.